Search

everythinglearnresearchcommunity

for

Search:↓

Skin health and diseases are closely linked to metabolic processes.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

People with certain skin conditions, especially androgenic alopecia, are more likely to have metabolic syndrome.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

A young Russian girl with Meier-Gorlin syndrome has two new mutations in the CDC6 gene.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

The plant extracts may help treat hair loss by promoting hair growth and reducing DHT levels.

Finasteride, a hair loss drug, has unaddressed sexual side effects due to the manufacturer's inadequate safety measures and lack of additional studies.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Microbial biofilms may cause red scrotum syndrome.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

The document concludes that an experimental drug may help wound healing in Epidermolysis Bullosa, links Hydroa vacciniforme to EBV, discusses diagnosing hair loss disorders, finds many children with eczema have allergies, reviews the safety of a skin medication in children, notes side effects of a Duchenne's treatment, and identifies a marker for pediatric mastocytosis.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The most common skin issues in females with Polycystic Ovary Syndrome (PCOS) are excessive hair growth, hair loss, oily skin, acne, dark skin patches, and skin tags, which may be linked to hormone and insulin levels.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

High levels of anti-Müllerian hormone can indicate polycystic ovarian syndrome in women who can have babies.

Mice without the vitamin D receptor gene lose hair due to disrupted hair follicle cycles.

People with reproductive, thyroid disorders, and type 2 diabetes can experience voice changes, but more research is needed to understand this better.

Different PCOS types respond uniquely to infertility treatments, with some having lower pregnancy rates and higher risks of complications.

Over half of the children had abnormal hair under a microscope, with many having genetic hair conditions.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

To diagnose Polycystic Ovarian Syndrome, two out of three signs—irregular periods, high male hormone levels, or cysts on the ovaries—are needed.

Skin side effects from cancer treatments can lead to changes in therapy and are common, with nail changes being the most frequent.